Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

240
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
240
Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Case Studies01:22

Case Studies

11.6K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
11.6K
Group Design02:01

Group Design

8.9K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
8.9K
Data Collection by Experiments01:13

Data Collection by Experiments

24.0K
Data collection is a systematic method of obtaining, observing, measuring, and analyzing accurate information. An experimental study is a standard method of data collection that involves the manipulation of the samples by applying some form of treatment prior to data collection. It refers to manipulating one variable to determine its changes on another variable. The sample subjected to treatment is known as “experimental units.”
An example of the experimental method is a public...
24.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential Parallel Comparison Design for Assessing Induction, Maintenance, Long-Term, and Other Treatment Effects on a Binary Endpoint.

Statistics in medicine·2026
Same author

Two-stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers.

Statistics in medicine·2024
Same author

A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker data.

Pharmaceutical statistics·2024
Same author

Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint.

Pharmaceutical statistics·2023
Same author

A generalized weighted combination test of treatment effect for clinical trials with a sequential parallel comparison design and binary endpoint.

Statistics in medicine·2022
Same author

Bivariate Bayesian hypothesis testing with missing data in components.

Pharmaceutical statistics·2021

Related Experiment Video

Updated: Jun 14, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real-World Setting.

Hui Quan1, Tong Li1, Xun Chen1

  • 1Biostatistics and Programming, Sanofi, Bridgewater, New Jersey, USA.

Pharmaceutical Statistics
|September 3, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel double inverse probability weighting (DIPW) method for analyzing real-world data (RWD). The DIPW approach estimates population average treatment effects (PATE) without requiring individual patient data (IPD), overcoming privacy challenges.

Keywords:
double inverse probability weighting (DIPW)individual patient datapropensity scorereal‐world datareal‐world evidence

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.4K

Related Experiment Videos

Last Updated: Jun 14, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.4K

Area of Science:

  • Biostatistics
  • Real-world data analysis
  • Epidemiology

Background:

  • Randomized clinical trials (RCTs) provide valuable data but cannot address all research questions.
  • Real-world data (RWD) offers broader insights but presents challenges due to patient privacy regulations restricting access to individual patient data (IPD).
  • Existing RWD analysis methods often struggle with generalizing findings due to data access limitations.

Purpose of the Study:

  • To propose a novel statistical method for analyzing real-world data (RWD) that overcomes individual patient data (IPD) access limitations.
  • To estimate the population average treatment effect (PATE) using summary statistics from RWD, ensuring patient privacy.
  • To develop a method that allows for the generalization of findings from available RWD endpoints to the broader target population.

Main Methods:

  • Introduction of a double inverse probability weighting (DIPW) approach for RWD analysis.
  • The DIPW method utilizes two stages of probability weighting: one for confounder distribution adjustment and another for endpoint data generalization.
  • Propensity scores and PATE estimation are formulated using only regional summary statistics, eliminating the need for IPD.

Main Results:

  • The proposed DIPW method enables PATE estimation without requiring access to individual patient data (IPD).
  • The method relies on summary statistics, making it feasible for cross-regional RWD analysis under privacy constraints.
  • Simulations demonstrated the performance of DIPW compared to modified and regular meta-analysis techniques.

Conclusions:

  • The DIPW approach provides a viable solution for analyzing RWD and estimating PATE while respecting patient privacy.
  • This method enhances the utility of RWD by enabling broader population-level inferences without compromising data confidentiality.
  • The DIPW approach is a significant advancement for leveraging RWD in clinical research and public health.